Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance

Diabetes

Volumn 50, Issue 6, 2001, Pages 1336-1343

  Moran, Antoinette ^a,c   Milla, Carlos ^a   Ducret, Rene ^a   Nair, K Sreekumaran ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CARBON 13; GLUCOSE; HYDROGEN; INSULIN; LEUCINE; NITROGEN 15; PHENYLALANINE;

ADULT; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; ENERGY EXPENDITURE; FEMALE; GLUCOSE INTOLERANCE; HEALTH STATUS; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN INFUSION; INSULIN RELEASE; INSULIN RESPONSE; INSULIN SENSITIVITY; LUNG FUNCTION; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS;

EID: 0034986829     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.6.1336     Document Type: Article

References (50)

1. Pancreatic endocrine function in cystic fibrosis
2. Pancreatic alpha and beta cell function in cystic fibrosis
3. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance
4. First-phase insulin release in adult cystic fibrosis patients: Correlation with clinical and biological parameters
5. Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance
6. Insulin sensitivity in cystic fibrosis
7. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis
8. Insulin sensitivity and insulin clearance in CF patients with normal and diabetic glucose tolerance
9. Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis
10. Insulin resistance is associated with decreased clinical status in cystic fibrosis
11. Diabetes mellitus in CF is characterized by islet amyloidosis
12. Abnormal glucose metabolism in cystic fibrosis
13. Diagnosis, screening, and management of CFRD: A consensus conference report
14. Trends in pulmonary function in cystic fibrosis patients correlate with the degree of glucose intolerance at baseline
15. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis
16. Diabetes mellitus associated with cystic fibrosis
17. Effect of intravenous insulin treatment on in vivo whole body leucine kinetics and oxygen consumption in insulin-deprived type 1 diabetic patients
18. Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis
19. Nutritional rehabilitation in cystic fibrosis: Controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease
20. Reduced incidence of respiratory tract infections in cystic fibrosis patients using aerosolized Dornase Alfa
21. Clinical research in diabetes and obesity. Part I. Methods, assessment and metabolic regulation
22. Differential regulation of amino acid exchange and protein dynamics across splanchnic and skeletal muscle beds by insulin in healthy human subjects
23. 13C]leucine infusion in man: A method for measuring human intracellular leucine tracer enrichment
24. 13C]leucine enrichment in human muscle protein
25. High performance liquid chromatographic determination of amino acids in the picomole range
26. Measurement of leucine metabolism in man from a primed, continuous infusion of L-[1-c-13]leucine
27. 5]phenylalanine model
28. Comparison of double and single isotope enzymatic derivative methods for measuring catecholamines in human plasma
29. Measuring clinical status in cystic fibrosis: Internal validity and reliability of a modified NIH score
30. A new prognostic score and clinical evaluation system for cystic fibrosis
31. A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes
32. Assessment of insulin sensitivity in vivo
33. Effectiveness and safety of small vs. large doses of enteric coated pancreatic enzymes in reducing steatorrhea in children with cystic fibrosis: A prospective randomized study
34. Comparison of weight-based dosages of enteric-coated microtablet enzyme preparations in patients with cystic fibrosis
35. Use of reciprocal pool specific activities to model leucine metabolism in humans
36. Regulation of whole-body leucine metabolism with insulin during mixed-meal absorption in normal and diabetic humans
37. Proteolysis associated with insulin resistance in cystic fibrosis
38. Effects of feeding on protein turnover in healthy children and in children with cystic fibrosis
39. Protein: Metabolism in type I diabetic patients
40. Protein: Metabolism in type II diabetes mellitus
41. Fasting and postmeal phenylalanine metabolism in mild type 2 diabetes
42. Leucine metabolism and body cell mass in cystic fibrosis
43. Protein metabolism in cystic fibrosis: Responses to malnutrition and murine supplementation
44. Altered body composition and muscle protein degradation in nutritionally growth-retarded children with cystic fibrosis
45. Whole body protein turnover in malnourished cystic fibrosis patients and its relationship to pulmonary disease
46. Elevated hepatic glucose production in children with cystic fibrosis
47. Energy needs and growth in children with cystic fibrosis
48. The effects of non-insulin dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues